Suppr超能文献

肾移植后早期蛋白尿的临床意义。

The clinical significance of early proteinuria after renal transplantation.

机构信息

Renal Transplant Unit, St. James's University Hospital NHS, Leeds, United Kingdom.

出版信息

Transplantation. 2010 Jan 27;89(2):200-7. doi: 10.1097/TP.0b013e3181c352c5.

Abstract

BACKGROUND

Late-onset proteinuria after renal transplantation has been universally associated with poor allograft outcomes. However, the significance of early low-grade posttransplant proteinuria remains uncertain.

METHODS

We analyzed the effect of proteinuria 3 months posttransplantation on death-censored graft loss, death with a functioning graft, vascular events within the graft's life, and estimated glomerular filtration rate at 5 years. Four hundred seventy-seven renal transplants from a single center (1988-2003) with a mean follow-up of 122 months were divided into four groups based on the median protein creatinine ratio (PCR) during the 3rd posttransplant month (PCR<0.15 [group 1, n=85]; PCR 0.15-0.5 [group 2, n=245]; PCR 0.5-1.00 [group 3, n=96]; PCR>1.00 [group 4, n=51]). Cox proportional hazards analysis was performed to study the impact of proteinuria on the various outcomes.

RESULTS

Multivariate analysis revealed that even low-level proteinuria at 3 months predicted death-censored graft failure (group 1 [reference]--hazard ratio [HR]=1, group 2--HR=7.1, group 3--HR = 10.5, group 4--HR 16.0; P=0.001). The impact on death and the occurrence of vascular events was only significant for group 4 (HR: 2.6; P=0.01 for death and HR: 2.2; P=0.04 for vascular events). Estimated glomerular filtration rate at 5 years was group 1, 48.5 mL/min; group 2, 41.2 mL/min; group 3, 31.1 mL/min; and group 4, 24.5 mL/min (P<0.001). Continued observation of group 2 to 1 year revealed adverse outcomes with increasing proteinuria.

CONCLUSIONS

Low-grade proteinuria at 3 months is associated with adverse clinical outcomes and identifies high-risk group of patients who may benefit from further intervention.

摘要

背景

肾移植后迟发性蛋白尿与移植物预后不良普遍相关。然而,早期轻度移植后蛋白尿的意义仍不确定。

方法

我们分析了移植后 3 个月蛋白尿对受者死亡、带功能移植物死亡、移植物内血管事件以及 5 年时估计肾小球滤过率的影响。单中心(1988-2003 年)477 例肾移植,平均随访 122 个月,根据移植后第 3 个月的尿蛋白/肌酐比值(PCR)中位数将患者分为 4 组(PCR<0.15[组 1,n=85];PCR 0.15-0.5[组 2,n=245];PCR 0.5-1.00[组 3,n=96];PCR>1.00[组 4,n=51])。采用 Cox 比例风险分析研究蛋白尿对各种结局的影响。

结果

多变量分析显示,即使在移植后 3 个月时存在低水平蛋白尿,也能预测受者死亡(组 1[参照]——风险比[HR]=1,组 2——HR=7.1,组 3——HR=10.5,组 4——HR=16.0;P=0.001)。对死亡和血管事件的影响仅在组 4 中具有显著性(死亡的 HR:2.6;P=0.01,血管事件的 HR:2.2;P=0.04)。5 年时的估计肾小球滤过率分别为组 1,48.5mL/min;组 2,41.2mL/min;组 3,31.1mL/min;组 4,24.5mL/min(P<0.001)。进一步观察组 2 至 1 年,发现蛋白尿逐渐增加与不良结局相关。

结论

移植后 3 个月时出现轻度蛋白尿与不良临床结局相关,并确定了高危患者群体,这些患者可能受益于进一步干预。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验